Nandrolone Decanoate-Induced Transient Ultrafiltration Failure in End Stage Renal Disease Patients Undergoing Dialysis.
- Author:
Seoung Woo LEE
1
;
Joon Ho SONG
;
Kyong Ju LEE
;
Gyeong A KIM
;
Moon Jae KIM
Author Information
1. Division of Nephrology-Hypertension, Department of Internal Medicine, Inha University College of Medicine, Inchon, Korea.
- Publication Type:Original Article
- Keywords:
Edema;
Ultrafiltration failure;
Nandroone decanoate;
End stage renal disase;
Hemodialysis;
Continuous ambuatory peritoneal dialysis
- MeSH:
Athletes;
Body Weight;
Dialysis*;
Edema;
Female;
Heart Failure;
Humans;
Hypoalbuminemia;
Incidence;
Kidney Failure, Chronic*;
Male;
Malnutrition;
Minoxidil;
Nandrolone*;
Peritoneal Dialysis, Continuous Ambulatory;
Prospective Studies;
Renal Dialysis;
Serum Albumin;
Steroids;
Ultrafiltration*
- From:Korean Journal of Nephrology
2000;19(4):687-695
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nandrolone decanoate(ND), one of the anabolic steroids, has been used by athletes to build muscle mass and enhance weight-lifting performance and has also shown to be useful in malnourished ESRD patients. However, ND has several adverse effects including edema. After we experienced a case of severe edema and transient ultrafiltration failure(TUF) requiring more frequent number of dialysis during ND treatment, we prospectively studied the incidence and clinical characteristics of TUF during ND treatment. Among 30 ND-treated patients, 7 patients developed TUF. All TUF+ patients were female and had sigificantly higher number of patients with congestive heart failure, more use of minoxidil and moderate to severe malnutrition than TUF- patients. There were no significant differences in age, duration of dialysis, and number of diabetics between TUF+ and TUF- group. In ND-treated male patients, the number of patients with CHF and moderate to severe malnutrition and with use of minoxidil were significantly lower than TUF+ ones. Body weight and serum albumin concentrations were significantly increased 2-3 months after ND treatment in TUF+ patients. But there were no differences in body weight and serum albumin in TUF-patients. In TUF+ patients, frequency of HD increased from 3 times to 4 to 6 times a week. CAPD patients with TUF+ had more frequently used 4.25% dialysate and number of exchanges were increased. In most TUF+ patients, severe edema and TUF were disappeared about 2 weeks after treatment. Most TUF+ patients returned to previous schedle of dialysis. In conclusion, ND seems to induce TUF in ESRD patients who had risk for volume regulation such as CHF, hypoalbuminemia, or the use of minoxidil.
